Close

Senior Staff at BIO

James C. Greenwood, President & CEO

James C. Greenwood is President and CEO of the Biotechnology Innovation Organization (BIO) in Washington, D.C., which represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

Tom DiLenge, President, Advocacy, Law & Public Policy Division

Tom DiLenge became President of BIO’s Advocacy, Law & Public Policy Division in April 2016. Immediately prior to that, he served as BIO's General Counsel and Head of Public Policy since December 2013.

Joanne M. Duncan, President, Membership and Business Operations Division

Joanne Duncan became President of BIO’s Membership and Business Operations Division in April 2016. Immediately prior to that, she served as the Senior Vice President of Finance and Administration and Chief Financial Officer since November 2011.

Brian Baenig, Executive Vice President, Food & Agriculture

Brian Baenig joined BIO on August 31, 2015 to serve as the Executive Vice President of the Food and Agriculture Section. Baenig comes to BIO from the U.S. Department of Agriculture (USDA), where he most recently served as Chief of Staff to Secretary Tom Vilsack.

Dan Durham, Executive Vice President, Health Policy

Dan Durham joined BIO in 2016 as Executive Vice President for Health Policy, bringing 30 years of leadership experience in health policy and regulatory issues. Previously, Dan held leadership positions at America’s Health Insurance Plans (AHIP), where he served as Interim CEO and Executive Vice President for Strategic Initiatives and Policy and Regulatory Affairs.

Brent Erickson , Executive Vice President, Industrial & Environmental

Brent Erickson is executive vice president in charge of the Industrial and Environmental Section at the Biotechnology Innovation Organization (BIO). BIO represents more than 1,200 biotechnology companies, academic institutions, and state biotechnology centers across the United States and in more than 30 other nations.

Cartier Esham, Executive Vice President, Emerging Companies

Cartier Esham serves as Executive Vice President for Emerging Companies at the Biotechnology Innovation Organization (BIO). In this role, Dr. Esham manages and directs BIO’s policy development, advocacy, research and educational initiatives for BIO’s emerging companies, which comprise approximately 90% of BIO’s membership.

Joseph Damond, Senior Vice President, International Affairs

Joseph Damond is Senior Vice President for International Affairs at the Biotechnology Innovation Organization (BIO), Damond is responsible for developing and implementing the industry association’s program of international advocacy and outreach, including the areas of trade policy and foreign government relations.

Jeanne Haggerty, Senior Vice President, Federal Government Relations

Jeanne Haggerty joined BIO in September 2006 as Director for Federal Government Relations. Prior to joining BIO, Haggerty served as a Professional Staff Member for the House Committee on Energy and Commerce.

Kay Holcombe, Senior Vice President, Science Policy

Kay Holcombe, Senior Vice President for Science Policy at the Biotechnology Innovation Organization, works with the organization on all major policy initiatives, with a particular focus on regulatory policy. Prior to joining BIO, she was Vice President, FDA Alliances and Federal Agency Relations, at Sanofi and Vice President for Government Relations at Genzyme Corporation.

Ken Lisaius, Senior Vice President, Communications

Ken Lisaius is BIO’s Senior Vice President of Communications. As Senior Vice President, he leads all communications operations for the organization. Prior to joining BIO, he was a senior-level public affairs counselor based in Washington, DC and worked with a diverse set of clients, both domestic and foreign, providing senior counsel and strategic communications advice.